Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

How to Manage Pain & Treatment in Elderly Patients

Richard Quinn  |  August 25, 2017

Communication also extends to geriatric patients. Dr. Singh says clear instructions and trust between patient and rheumatologist are key. One of his patients developed fatigue, called his primary care provider, and due to some memory problems, did not indicate he was taking methotrexate. The patient was referred to cardiology and underwent a cardiac catheterization procedure.

“Talking to the rheumatologist could prevent a lot of harm to the patient. Fatigue could be a side effect of any medication,” Dr. Singh says. “Proper communication between the rheumatologist and the geriatrician or primary care [provider] can avoid unnecessary interventions, improve patient safety and reduce the cost of care. Sometimes, we forget to take a step back, look at the patient as a whole and think about what else could be wrong.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Bauer, who is co-founder of the Young Rheumatologists Association, says it is always exciting to work with primary care providers and geriatricians who know their patients well.

“They are on the lookout for complications from medications, and the patient really trusts them,” she says, adding that rheumatologists should build on those relationships. “Patients don’t always understand what rheumatology really is and very often show up very scared and confused.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Singh agrees and considers his partnerships with geriatricians essential.

“Rheumatologists are team players. We need to talk to primary care, geriatrics and the specialists,” he says. “We need to work in combination with the care team to improve patient care.”


Richard Quinn is a freelance writer in New Jersey.

References

  1. Staff. American generation fast facts. CNN. 2016 Oct 20.
  2. Hochberg M, Altman R, April KT, et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken). 2012 Apr;64(4):465–474. DOI 10.1002/acr.21596.
  3. Rahme E, Bernatsky S. NSAIDs and risk of lower gastrointestinal bleeding. Lancet. 2010 Jun 10;376(9736):146–148.

Page: 1 2 3 | Single Page
Share: 

Filed under:Practice Support Tagged with:elderlygeriatricgeriatricspatient careTreatment

Related Articles
    A Comprehensive Review of NSAID Cardiovascular Toxicity

    A Comprehensive Review of NSAID Cardiovascular Toxicity

    July 18, 2018

    Non-steroidal anti-inflammatory drugs (NSAIDs) are the most used drugs for acute and chronic pain. More than 30 billion doses of NSAIDs are consumed annually from more than 70 million prescriptions.1 Despite their common use, NSAIDs are not free of serious toxicities. In the pre-Vioxx (rofecoxib) era, gastrointestinal toxicity was the primary concern for many NSAIDs….

    As Population Ages, Rheumatologists Prepare to Treat Elderly Patients with More Comorbidities

    November 1, 2012

    Cardiovascular disease, diabetes are among the conditions that add another layer of complexity in treating older rheumatology patients

    NSAIDs: The Heart of the Controversy

    June 1, 2007

    Rheumatologists on the AHA statement and how to balance NSAID risks and benefits

    Pain Management Research Sheds Light on Postsurgical Pain Sensitization, Opioid Risks, Nondrug Interventions

    March 20, 2017

    WASHINGTON, D.C.—Successful management of pain remains a challenge for rheumatologists. Five research abstracts presented at the 2016 ACR/ARHP Annual Meeting in a session titled Pain—Basic and Clinical Aspects offered new insights on pain sensitization, and the risks and effects of various pain therapies. Knee Pain After Surgery Can we predict which patients will have longer-term…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences